Capillary cerebral amyloid angiopathy identifies a distinct APOE ε4-associated subtype of sporadic Alzheimer’s disease

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

A New Clinical Scale for the Staging of Dementia

Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056 · see citing works

Categorical Data Analysis

Agresti, A. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/0471249688 · Cited by 6,746 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · see citing works

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · see citing works

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676 · see citing works

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · see citing works

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · see citing works

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933 · see citing works

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859 · see citing works

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · see citing works

Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease

Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,833 · see citing works

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · see citing works

Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease

HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542 · see citing works

The human nervous system

Paxinos, G., & Jürgen, K. (2004) · Cited by 1,482 · see citing works

Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease

(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981 · see citing works

Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease

Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., McKhann, G. M., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm.1868 · Cited by 935 · see citing works

Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease

Bell, R. D., & Zloković, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 855 · see citing works

Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

Wang, X., Su, B., Siedlak, S. L., Moreira, P. I., Fujioka, H., Wang, Y., Casadesus, G., & Zhu, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804871105 · Cited by 835 · see citing works

Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome

Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.003 · Cited by 780 · see citing works

apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain

Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · see citing works

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769 · see citing works

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

Salloway, S., Sperling, R., Gilman, S., Fox, N. C., Blennow, K., Raskind, M., Sabbagh, M., Honig, L. S., Doody, R., van Dyck, C. H., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c67808 · Cited by 753 · see citing works

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses

Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747 · see citing works

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.

Roher, A. E., Lowenson, J. D., Clarke, S., Woods, A. S., Cotter, R. J., Gowing, E., & Ball, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10836 · Cited by 740 · see citing works

Cerebral Amyloid Angiopathy

Weller, R. O., Massey, A., Newman, T. A., Hutchings, M., Kuo, Y.-M., & Roher, A. E. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65616-7 · Cited by 679 · see citing works

The National Institute on Aging.

Stahl, S. (1998) · Medical Care · doi:10.1097/00005650-199808000-00002 · Cited by 627 · see citing works

Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections

Braak, H., & Braak, E. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00661.x · Cited by 598 · see citing works

Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques

Saido, T. C., Iwatsubo, T., Mann, D. M. A., Shimada, H., Ihara, Y., & Kawashima, S. (1995) · Neuron · doi:10.1016/0896-6273(95)90301-1 · Cited by 587 · see citing works

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571 · see citing works

Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway

Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563 · see citing works

Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE

Bertram, L., Lange, C., Mullin, K., Parkinson, M., Hsiao, M., Hogan, M. F., Schjeide, B. M. M., Hooli, B., DiVito, J., Ionita, I., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.10.008 · Cited by 511 · see citing works

Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease

Esiri, M. M., Nagy, Z., Smith, M. Z., Barnetson, L., & Smith, A. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02355-7 · Cited by 493 · see citing works

Lymphatic drainage of the brain and the pathophysiology of neurological disease

Weller, R. O., Djuanda, E., Yow, H.-Y., & Carare, R. O. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0457-0 · Cited by 488 · see citing works

Two Types of Sporadic Cerebral Amyloid Angiopathy

Thal, D. R., Ghebremedhin, E., Rüb, U., Yamaguchi, H., Del Tredici, K., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.282 · Cited by 446 · see citing works

Distribution of the ?2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues

Moestrup, S. K., Gliemann, J., & Pallesen, G. (1992) · Cell and Tissue Research · doi:10.1007/bf00353892 · Cited by 392 · see citing works

Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline

Thal, D. R., Ghebremedhin, E., Orantes, M., & Wiestler, O. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1287 · Cited by 384 · see citing works

Activation of the classical complement pathway in brain tissue of Alzheimer patients

McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90843-4 · Cited by 383 · see citing works

Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease

Thal, D. R., Griffin, W. S. T., de Vos, R. A. I., & Ghebremedhin, E. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0366-2 · Cited by 372 · see citing works

Sequence of Aβ-protein deposition in the human medial temporal lobe

Thal, D. R., Rüb, U., Schultz, C., Sassin, I., Ghebremedhin, E., Del Tredici, K., Braak, E., & Braak, H. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.8.733 · Cited by 370 · see citing works

Modulation of amyloid β-protein clearance and Alzheimer’s disease susceptibility by the LDL receptor–related protein pathway

Kang, D. E., Pietrzik, C. U., Baum, L., Chevallier, N., Merriam, D. E., Kounnas, M. Z., Wagner, S. L., Troncoso, J. C., Kawas, C. H., Katzman, R., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11013 · Cited by 354 · see citing works

Vascular pathology in the aged human brain

Grinberg, L. T., & Thal, D. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0652-7 · Cited by 345 · see citing works

Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease

Kang, D. E., Saitoh, T., Chen, X., Xia, Y., Masliah, E., Hansen, L. A., Thomas, R. G., Thal, L. J., & Katzman, R. (1997) · Neurology · doi:10.1212/wnl.49.1.56 · Cited by 298 · see citing works

Neuropathological evaluation of mixed dementia

Jellinger, K. A., & Attems, J. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.045 · Cited by 273 · see citing works

Interleukin-1 mediates Alzheimer and Lewy body pathologies

Griffin, W. S. T., Liu, L., Li, Y., Mrak, R. E., & Barger, S. W. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-5 · Cited by 262 · see citing works

α2‐Macroglobulin Complexes with and Mediates the Endocytosis of β‐Amyloid Peptide via Cell Surface Low‐Density Lipoprotein Receptor‐Related Protein

Narita, M., Holtzman, D. M., Schwartz, A. L., & Bu, G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051904.x · Cited by 259 · see citing works

The Biphasic Relationship between Regional Brain Senile Plaque and Neurofibrillary Tangle Distributions: Modification by Age, Sex, and <i>APOE</i> Polymorphism

CORDER, E. H., GHEBREMEDHIN, E., TAYLOR, M. G., THAL, D. R., OHM, T. G., & BRAAK, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.005 · Cited by 254 · see citing works

Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease

Wilcock, D. M., Vitek, M. P., & Colton, C. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.023 · Cited by 249 · see citing works

Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria

Braak, H., & Braak, E. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050096 · Cited by 225 · see citing works

Pathology of Cerebrospinal Fluid and Interstitial Fluid of the CNS: Significance for Alzheimer Disease, Prion Disorders and Multiple Sclerosis

Weller, R. O. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199810000-00001 · Cited by 224 · see citing works

Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone

Hyman, B. T., Hoesen, G. W. V., & Damásio, A. R. (1987) · Annals of Neurology · doi:10.1002/ana.410220110 · Cited by 219 · see citing works

APOE ε4 Genotype and Longitudinal Changes in Cerebral Blood Flow in Normal Aging

Thambisetty, M., Beason‐Held, L. L., An, Y., Kraut, M. A., & Resnick, S. M. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.913 · Cited by 211 · see citing works

Increased Brain β-Amyloid Load, Phosphorylated Tau, and Risk of Alzheimer Disease Associated With an Intronic CYP46 Polymorphism

Papassotiropoulos, A., Streffer, J. R., Tsolaki, M., Schmid, S., Thal, D. R., Nicosia, F. M., Iakovidou, V., Maddalena, A. S., Lütjohann, D., Ghebremedhin, E., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.1.29 · Cited by 208 · see citing works

Alzheimer’s disease: the lipid connection

Hartmann, T., Kuchenbecker, J., & Grimm, M. O. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04715.x · Cited by 199 · see citing works

Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology?a pilot study

Attems, J., & Jellinger, K. A. (2004) · Acta Neuropathologica · doi:10.1007/s00401-003-0796-9 · Cited by 179 · see citing works

Alzheimer disease pathology as a host response

Castellani, R. J., Lee, H.-G., Zhu, X., Perry, G., & Smith, M. A. (2008) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/nen.0b013e318177eaf4 · Cited by 171 · see citing works

Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses

Takahashi, R. H., Capetillo-Zarate, E., Lin, M. T., Milner, T. A., & Gouras, G. K. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.021 · Cited by 150 · see citing works

Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease

Kölsch, H., Lütjohann, D., Ludwig, M. Z., Schulte, A., Ptok, U., Jessen, F., von Bergmann, K., Rao, M. L., Maier, W., & Heun, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001109 · Cited by 139 · see citing works

Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances

Thal, D. R., Capetillo-Zarate, E., Larionov, S., Staufenbiel, M., Zurbruegg, S., & Beckmann, N. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.017 · Cited by 138 · see citing works

Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins

Reid, P., Urano, Y., Kodama, T., & Hamakubo, T. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00054.x · Cited by 129 · see citing works

Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis

Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · cited 1× · see citing works

Accumulation of intraneuronal Aβ correlates with ApoE4 genotype

Christensen, D. Z., Schneider-Axmann, T., Lucassen, P. J., Bayer, T. A., & Wirths, O. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0666-1 · Cited by 120 · see citing works

Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study

Milton, I. D., Banner, S. J., Ince, P. G., Piggott, N. H., Fray, A. E., Thatcher, N. M., Horne, C. H. W., & Shaw, P. J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00233-7 · Cited by 119 · see citing works

N-terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits

Tekirian, T. L., Saido, T. C., Markesbery, W. R., Russell, M. J., Wekstein, D. R., Patel, E., & Geddes, J. W. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199801000-00009 · Cited by 101 · see citing works

Argyrophilic grains: A distinct disease or an additive pathology?

Josephs, K. A., Whitwell, J. L., Parisi, J. E., Knopman, D. S., Boeve, B. F., Geda, Y. E., Jack, C. R., Petersen, R. C., & Dickson, D. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.032 · Cited by 97 · see citing works

Increased expression of cholesterol 24S‐hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer’s disease

Tian, G., Kong, Q., Lai, L., Ray‐Chaudhury, A., & Lin, C. G. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06661.x · Cited by 87 · see citing works

Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy

Attems, J., Lauda, F., & Jellinger, K. A. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0674-4 · Cited by 87 · see citing works

Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function

Zhong, N., Ramaswamy, G., & Weisgraber, K. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014464 · Cited by 85 · see citing works

The Effect of 24S-Hydroxycholesterol on Cholesterol Homeostasis in Neurons: Quantitative Changes to the Cortical Neuron Proteome

Wang, Y., Muneton, S., Sjövall, J., Jovanovic, J. N., & Griffiths, W. J. (2008) · Journal of Proteome Research · doi:10.1021/pr7006076 · Cited by 81 · see citing works

Cerebral Small Vessel Disease-Induced Apolipoprotein E Leakage Is Associated With Alzheimer Disease and the Accumulation of Amyloid β-Protein in Perivascular Astrocytes

Utter, S., Tamboli, I. Y., Walter, J., Upadhaya, A. R., Birkenmeier, G., Pietrzik, C. U., Ghebremedhin, E., & Thal, D. R. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181836a71 · Cited by 79 · see citing works

Fleecy Amyloid Deposits in the Internal Layers of the Human Entorhinal Cortex are Comprised of N-terminal Truncated Fragments of Aβ

Thal, D. R., Sassin, I., Schultz, C., Haass, C., Braak, E., & Braak, H. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199902000-00010 · Cited by 77 · see citing works

Apolipoprotein E4 domain interaction: Synaptic and cognitive deficits in mice

Zhong, N., Scearce-Levie, K. A., Ramaswamy, G., & Weisgraber, K. H. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.01.006 · Cited by 76 · see citing works

The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease‐related pathology

Thal, D. R., Schultz, C., Botez, G., Del Tredici, K., Mrak, R. E., Griffin, W. S. T., Wiestler, O. D., Braak, H., & Ghebremedhin, E. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00635.x · Cited by 69 · see citing works

Cholesterol 25-Hydroxylase on Chromosome 10q Is a Susceptibility Gene for Sporadic Alzheimer’s Disease

Papassotiropoulos, A., Lambert, J., Vrièze, F. W., Wollmer, M. A., von der Kammer, H., Streffer, J. R., Maddalena, A. S., Huynh, K.-D., Wolleb, S., Lütjohann, D., et al. (2005) · Neurodegenerative Diseases · doi:10.1159/000090362 · Cited by 64 · see citing works

Occurrence and co-localization of amyloid β-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice

Thal, D. R., Larionov, S., Abramowski, D., Wiederhold, K., Dooren, T. V., Yamaguchi, H., Haass, C., LEUVEN, F. V., Staufenbiel, M., & Capetillo‐Zarate, E. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.029 · Cited by 58 · see citing works

Silver Labeling of Alzheimer Neurofibrillary Changes and Brain β-Amyloid

Iqbal, K., Braak, H., Braak, E., & Grundke, I. (1993) · Journal of Histotechnology · doi:10.1179/his.1993.16.4.335 · Cited by 52 · see citing works

Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles.

Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K. A., SEITELBERGER, F., Grundke, I., Iqbal, K., & Hm, W. (1989) · PubMed · Cited by 52 · see citing works

Excitatory Amino Acid Transporter EAAT‐2 in Tangle‐bearing Neurons in Alzheimer's Disease

Thal, D. R. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00457.x · Cited by 49 · see citing works

CYP46A1variants influence Alzheimer’s disease risk and brain cholesterol metabolism

Kölsch, H., Lütjohann, D., Jessen, F., Popp, J., Hentschel, F., Kelemen, P. B., Schmitz, S., Maier, W., & Heun, R. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2008.12.005 · Cited by 44 · see citing works

Tau antigenic changes induced by glutamate in rat primary culture model: a biochemical approach.

Sautiére, P., Sindou, P., Couratier, P., Hugon, J., Wattez, A., & Delacourte, A. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90104-f · Cited by 31 · see citing works

Genetic–morphologic association study: association between the low density lipoprotein‐receptor related protein (LRP) and cerebral amyloid angiopathy

Christoforidis, M., Schober, R., & Krohn, K. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00614.x · Cited by 30 · see citing works

Improved method facilitates reliable APOE genotyping of genomic DNA extracted from formaldehyde-fixed pathology specimens

Ghebremedhin, E., Braak, H., Braak, E., & Sahm, J. (1998) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(97)00197-0 · Cited by 23 · see citing works

EAAT1 and EAAT2 immunoreactivity in transgenic mice with a G93A mutant SOD1 gene

Sasaki, S., Warita, H., Abe, K., Komori, T., & Iwata, M. (2001) · Neuroreport · doi:10.1097/00001756-200105250-00014 · Cited by 21 · see citing works

Genetic association of argyrophilic grain disease with polymorphisms in alpha‐2 macroglobulin and low‐density lipoprotein receptor‐related protein genes

Ghebremedhin, E., Schultz, C., Thal, D. R., Tredici, K. D., Rueb, U., & Braak, H. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00398.x · Cited by 21 · see citing works

The neuropathological diagnosis of Alzheimer's disease

DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329 · see citing works

Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways

Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947 · see citing works

Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum

Charidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611 · see citing works

The probabilistic model of Alzheimer disease: the amyloid hypothesis revised

Frisoni, G. B., Altomare, D., Thal, D. R., Ribaldi, F., van der Kant, R., Ossenkoppele, R., Blennow, K., Cummings, J., van Duijn, C., Nilsson, P. M., et al. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00533-w · Cited by 513 · see citing works

Neuropathology of Alzheimer's Disease

Trejo‐Lopez, J. A., Yachnis, A. T., & Prokop, S. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01146-y · Cited by 398 · see citing works

Review: sporadic cerebral amyloid angiopathy

Attems, J., Jellinger, K., Thal, D. R., & Van Nostrand, W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01137.x · Cited by 371 · see citing works

Cerebral Amyloid Angiopathy: Emerging Concepts

Yamada, M. (2015) · Journal of Stroke · doi:10.5853/jos.2015.17.1.17 · Cited by 367 · see citing works

The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model

Bateman, R. J., Benzinger, T. L., Berry, S., Clifford, D. B., Duggan, C., Fagan, A. M., Fanning, K., Farlow, M. R., Hassenstab, J., McDade, E. M., et al. (2017) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2016.07.005 · Cited by 303 · see citing works

Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies

Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075796 · Cited by 297 · see citing works

Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline

Østergaard, L., Engedal, T. S., Moreton, F. C., Hansen, M. B., Wardlaw, J. M., Dalkara, T., Markus, H. S., & Muir, K. W. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15606723 · Cited by 283 · see citing works

Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease

Spina, S., La Joie, R., Petersen, C., Nolan, A. L., Cuevas, D., Cosme, C., Hepker, M., Hwang, J.-H., Miller, Z. A., Huang, E. J., et al. (2021) · Brain · doi:10.1093/brain/awab099 · Cited by 278 · see citing works

Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?

Govindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 271 · see citing works

The role of APOE in cerebrovascular dysfunction

Tai, L. M., Thomas, R., Marottoli, F. M., Koster, K. P., Kanekiyo, T., Morris, A. W. J., & Bu, G. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1547-z · Cited by 231 · see citing works

Loss of Astrocyte Polarization in the Tg-ArcSwe Mouse Model of Alzheimer's Disease

Yang, J., Lunde, L. K., Nuntagij, P., Oguchi, T., Camassa, L. M. A., Nilsson, L. N. G., Lannfelt, L., Xu, Y., Amiry-Moghaddam, M. R., Ottersen, O. P., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110725 · Cited by 228 · see citing works

Review: Cerebral amyloid angiopathy, prion angiopathy, <scp>CADASIL</scp> and the spectrum of protein elimination failure angiopathies (<scp>PEFA</scp>) in neurodegenerative disease with a focus on therapy

Carare, R. O., Hawkes, C. A., Jeffrey, M., Kalaria, R. N., & Weller, R. O. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12042 · Cited by 207 · see citing works

Multifaceted roles of APOE in Alzheimer disease

Jackson, R. J., Hyman, B. T., & Serrano-Pozo, A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00988-2 · Cited by 193 · see citing works

Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease

Liao, F., Yoon, H., & Kim, J. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000383 · Cited by 191 · see citing works

The <i>APOE</i> ε4/ε4 Genotype Potentiates Vascular Fibrin(Ogen) Deposition in Amyloid-Laden Vessels in the Brains of Alzheimer's Disease Patients

Hultman, K., Strickland, S., & Norris, E. H. (2013) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/jcbfm.2013.76 · Cited by 183 · see citing works

Disruption of Arterial Perivascular Drainage of Amyloid-β from the Brains of Mice Expressing the Human APOE ε4 Allele

Hawkes, C. A., Sullivan, P. M., Hands, S. L., Weller, R. O., Nicoll, J. A. R., & Carare, R. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041636 · Cited by 177 · see citing works

Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes

Brenowitz, W. D., Nelson, P. T., Besser, L. M., Heller, K., & Kukull, W. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.028 · Cited by 174 · see citing works

Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue

Love, S., Chalmers, K. A., Ince, P. G., Esiri, M. M., Attems, J., Jellinger, K., Yamada, M., McCarron, M., Minett, T., Fiona, M., et al. (2014) · Europe PMC (PubMed Central) · doi:10.25405/ncl.34306728 · Cited by 167 · see citing works

Challenges of multimorbidity of the aging brain: a critical update

Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154 · see citing works

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020

Hampel, H. J., Lista, S., Teipel, S. J., Garaci, F., Nisticò, R., Blennow, K., Zetterberg, H., Bertram, L., Duyckaerts, C. J., Bakardjian, H., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.009 · Cited by 141 · see citing works

The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome

Davidson, Y. S., Robinson, A., Prasher, V. P., & Mann, D. M. A. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0559-4 · Cited by 141 · see citing works

The role of astrocytes in amyloid β-protein toxicity and clearance

Thal, D. R. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.04.021 · Cited by 141 · see citing works

Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives

Fisher, R. A., Miners, J. S., & Love, S. (2022) · Brain Pathology · doi:10.1111/bpa.13061 · Cited by 127 · see citing works

Stages of granulovacuolar degeneration: their relation to Alzheimer’s disease and chronic stress response

Thal, D. R., Tredici, K. D., Ludolph, A. C., Hoozemans, J. J. M., Rozemüller, A. J. M., Braak, H., & Knippschild, U. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0871-6 · Cited by 123 · see citing works

Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study

Calì, I., Cohen, M. L., Haı̈k, S., Parchi, P., Giaccone, G., Collins, S. J., Kofskey, D., Wang, H., McLean, C., Brandel, J., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0503-z · Cited by 120 · see citing works

Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease

Shinohara, M., Murray, M. E., Frank, R. D., Shinohara, M., DeTure, M., Yamazaki, Y., Tachibana, M., Atagi, Y., Davis, M. D., Liu, C.-C., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1580-y · Cited by 123 · see citing works

APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease

Reinvang, I., Espeseth, T., & Westlye, L. T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.05.006 · Cited by 104 · see citing works

Capillary cerebral amyloid angiopathy in Alzheimer’s disease: association with allocortical/hippocampal microinfarcts and cognitive decline

Hecht, M., Krämer, L. M., Arnim, C., Otto, M., & Thal, D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1834-y · Cited by 92 · see citing works

The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier

Magaki, S., Tang, Z., Tung, S., Williams, C. K., Lo, D., Yong, W. H., Khanlou, N., & Vinters, H. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.004 · Cited by 93 · see citing works

The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death

Thal, D. R., & Tomé, S. O. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.006 · Cited by 85 · see citing works

Cerebral Amyloid Angiopathy

(2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00006-0 · Cited by 84 · see citing works

Clinical Predictors of Severe Cerebral Amyloid Angiopathy and Influence ofAPOEGenotype in Persons With Pathologically Verified Alzheimer Disease

Ringman, J. M., Sachs, M. C., Zhou, Y. F., Monsell, S. E., Saver, J. L., & Vinters, H. V. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.681 · Cited by 82 · see citing works

Pathology of clinical and preclinical Alzheimer’s disease

Thal, D. R., Arnim, C. A. F. V., Griffin, W. S. T., Yamaguchi, H., Mrak, R. E., Attems, J., & Upadhaya, A. R. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0449-5 · Cited by 78 · see citing works

Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models

Liao, F., Zhang, T. J., Jiang, H., Lefton, K. B., Robinson, G. O., Vassar, R., Sullivan, P. M., & Holtzman, D. M. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0250-y · Cited by 77 · see citing works

Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s disease

Mann, D. M. A., Davidson, Y. S., Robinson, A. C., Allen, N., Hashimoto, T., Richardson, A., Jones, M., Snowden, J. S., Pendleton, N., Potier, M.-C., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1866-3 · Cited by 73 · see citing works

High‐molecular weight Aβ oligomers and protofibrils are the predominant Aβ species in the native soluble protein fraction of the AD brain

Upadhaya, A. R., Lungrin, I., Yamaguchi, H., Fändrich, M., & Thal, D. R. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01306.x · Cited by 73 · see citing works

The Role of Cholesterol Metabolism in Alzheimer’s Disease

Sun, J.-H., Yu, J.-T., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8749-y · Cited by 70 · see citing works

TDP-43 pathology is associated with increased tau burdens and seeding

Tomé, S. O., Tsaka, G., Ronisz, A., Ospitalieri, S., Gawor, K., Gomes, L. A., Otto, M., Arnim, C. A. F. V., Damme, P. V., Bosch, L. V. D., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00653-0 · Cited by 67 · see citing works

Role of Thiamine in Alzheimer's Disease

Lương, K. V. Q., & Nguyễn, L. (2011) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317511432736 · Cited by 64 · see citing works

Capillary CAA and perivascular Aβ-deposition: Two distinct features of Alzheimer's disease pathology

Attems, J., Yamaguchi, H., Saido, T. C., & Thal, D. R. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.030 · Cited by 63 · see citing works

Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer’s disease and apoE TR mouse cortex

Arold, S. P., Sullivan, P. M., Bilousova, T. V., Teng, E., Miller, C. A., Poon, W. W., Vinters, H. V., Cornwell, L. B., Saing, T., Cole, G. M., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0892-1 · Cited by 57 · see citing works

The case for blood–brain barrier dysfunction in the pathogenesis of Alzheimer's disease

Jeynes, B., & Provias, J. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22527 · Cited by 51 · see citing works

Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy

Camacho, J., Moliné, T., Bonaterra‐Pastra, A., y Cajal, S. R., Martínez-Sáez, E. A., & Hernández‐Guillamón, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00187 · Cited by 51 · see citing works

Patterns of cerebral amyloid angiopathy define histopathological phenotypes in A lzheimer's disease

Allen, N., Robinson, A., Snowden, J. S., Davidson, Y. S., & Mann, D. M. A. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12070 · Cited by 49 · see citing works

Blocking the Apolipoprotein E/Amyloid-β Interaction Reduces Fibrillar Vascular Amyloid Deposition and Cerebral Microhemorrhages in TgSwDI Mice

Yang, J., Ji, Y., Mehta, P. D., Bates, K. A., Sun, Y., & Wısnıewskı, T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101401 · Cited by 48 · see citing works

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers

Thal, D. R., Poesen, K., Vandenberghe, R. R., & Meyer, S. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00819-y · Cited by 47 · see citing works

Contact sport participation and chronic traumatic encephalopathy are associated with altered severity and distribution of cerebral amyloid angiopathy

Standring, O. J., Friedberg, J., Tripodis, Y., Chua, A. S., Cherry, J. D., Alvarez, V. E., Huber, B. R., Xia, W., Mez, J. B., Alosco, M. L., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02031-x · Cited by 47 · see citing works

Neprilysin Protects against Cerebral Amyloid Angiopathy and Aβ‐Induced Degeneration of Cerebrovascular Smooth Muscle Cells

Miners, J. S., Kehoe, P. G., & Love, S. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00486.x · Cited by 45 · see citing works

Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease

Petralla, S., Panayotova, M., Franchina, E., Fricker, G., & Puris, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070948 · Cited by 44 · see citing works

The Senescence Hypothesis of Disease Progression in Alzheimer Disease: an Integrated Matrix of Disease Pathways for FAD and SAD

Hunter, S., Arendt, T., & Brayne, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8445-3 · Cited by 46 · see citing works

LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease

Koper, M. J., Tomé, S. O., Gawor, K., Belet, A., Schoor, E. V., Schaeverbeke, J. M., Vandenberghe, R. R., Vandenbulcke, M., Ghebremedhin, E., Otto, M., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01432-6 · Cited by 41 · see citing works

Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease

Zekonyte, J., Sakai, K., Nicoll, J. A. R., Weller, R. O., & Carare, R. O. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.025 · Cited by 40 · see citing works

The Beneficial Role of Vitamin D in Alzheimer’s Disease

Lương, K. V. Q., & Nguyễn, L. (2011) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317511429321 · Cited by 40 · see citing works

Predicting Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhages and Other Cerebrovascular Disorders in Alzheimer’s Disease

Yamada, M. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00064 · Cited by 38 · see citing works

Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer’s disease?

Carbone, M. G., Pagni, G., Tagliarini, C., Imbimbo, B. P., & Pomara, N. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101420 · Cited by 37 · see citing works

Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer’s disease

Rolyan, H., Feike, A. C., Upadhaya, A. R., Waha, A., Dooren, T. V., Haass, C., Birkenmeier, G., Pietrzik, C. U., LEUVEN, F. V., & Thal, D. R. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0572-7 · Cited by 36 · see citing works

APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice

Pankiewicz, J. E., Baquero-Buitrago, J., Sanchez, S., Lopez-Contreras, J., Kim, J., Sullivan, P. M., Holtzman, D. M., & Sadowski, M. J. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0156-1 · Cited by 34 · see citing works

Cerebral Superficial Siderosis

Weidauer, S., Neuhaus, E., & Hattingen, E. (2022) · Clinical Neuroradiology · doi:10.1007/s00062-022-01231-5 · Cited by 34 · see citing works

DHCR24 reverses Alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xFAD mice

Zhang, W.-B., Huang, Y. M., Guo, X., Zhang, M.-Q., Yuan, X.-S., & Zu, H. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01593-y · Cited by 34 · see citing works

Capillary Amyloid-β Protein Deposition in a Population-Based Study (Vantaa 85+)

Mäkelä, M., Paetau, A., Polvikoski, T., Myllykangas, L., & Tanskanen, M. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150241 · Cited by 31 · see citing works

Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy

de Wit, N. M., Snkhchyan, H., den Hoedt, S., Wattimena, D. J. L., de Vos, R., Mulder, M. T., Walter, J., Martínez‐Martínez, P., Hoozemans, J. J. M., Rozemüller, A. J. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160551 · Cited by 30 · see citing works

The hippocampal sparing subtype of Alzheimer’s disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review

Ferreira, D., Mohanty, R., Murray, M. E., Nordberg, A. K., Kantarci, K., & Westman, E. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01471-z · Cited by 30 · see citing works

EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review

Wood, O. W. G., Yeung, J. H. Y., Faull, R. L. M., & Kwakowsky, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.952096 · Cited by 29 · see citing works

The influence of APOEε4 on the pTau interactome in sporadic Alzheimer’s disease

Thierry, M., Ponce, J., Martá-Ariza, M., Askenazi, M., Faustin, A., Leitner, D., Pires, G., Kanshin, E., Drummond, E., Ueberheide, B. M., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02744-8 · Cited by 27 · see citing works

Amyloid-Beta Pathology and Cognitive Performance in Centenarians

Rohde, S. K., Luimes, M. C., Lorenz, L. M. C., Fierro‐Hernández, P., Rozemüller, A. J. M., Hulsman, M., Zhang, M., Graat, M., van der Hoorn, M. E., Daatselaar, D., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1734 · Cited by 23 · see citing works

Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease

Lloyd, G. M., Trejo‐Lopez, J. A., Xia, Y., McFarland, K. N., Lincoln, S., Ertekin‐Taner, N., Giasson, B. I., Yachnis, A. T., & Prokop, S. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0891-3 · Cited by 23 · see citing works

Antioxidant Status and APOE Genotype As Susceptibility Factors for Neurodegeneration in Alzheimer's Disease and Vascular Dementia

Zito, G., Polimanti, R. A., Panetta, V., Ventriglia, M., Salustri, C., Siotto, M., Moffa, F., Altamura, C., Vernieri, F., Lupoi, D., et al. (2012) · Rejuvenation Research · doi:10.1089/rej.2012.1383 · Cited by 22 · see citing works

Neurodegenerative Diseases and Ageing

Walker, L., McAleese, K. E., Erskine, D., & Attems, J. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_4 · Cited by 21 · see citing works

Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy

Inoue, Y., Ando, Y., Misumi, Y., & Ueda, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083869 · Cited by 21 · see citing works

Senile plaques in Alzheimer's disease arise from Aβ‐ and Cathepsin D‐enriched mixtures leaking out during intravascular haemolysis and microaneurysm rupture

Fu, H., Li, J., Du, P., Jin, W., Gao, G., & Cui, D. (2022) · FEBS Letters · doi:10.1002/1873-3468.14549 · Cited by 20 · see citing works

Alzheimer Disease and Cellular Mechanisms of Memory Storage

Arshavsky, Y. I. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000043 · Cited by 19 · see citing works

Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total‐Aβ42/Aβ40 ratio

Slemmon, J. R., Shapiro, A., Mercken, M. H., Streffer, J. R., Romano, G. J., Andreasen, N., Zetterberg, H., & Blennow, K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13297 · Cited by 18 · see citing works

Alzheimer's disease and its co‐pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4

Gawor, K., Verrept, S., Arekatla, G., Wouters, D., Ronisz, A., Hecht, M., Laureyssen, C., Donck, H. V., Lahaije, B., Ospitalieri, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70483 · Cited by 17 · see citing works

Atrophy patterns in cerebral amyloid angiopathy with and without cortical superficial siderosis

Kim, J.-H., Na, H. K., Shin, J., Kim, H. J., Seo, S. W., Seong, J., & Na, D. L. (2018) · Neurology · doi:10.1212/wnl.0000000000005524 · Cited by 16 · see citing works

Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy?

Zedde, M., Piazza, F., & Pascarella, R. (2025) · Biomedicines · doi:10.3390/biomedicines13040881 · Cited by 12 · see citing works

Cerebral Amyloid Angiopathy: Clinical Presentation, Sequelae and Neuroimaging Features—An Update

Weidauer, S., & Hattingen, E. (2025) · Biomedicines · doi:10.3390/biomedicines13030603 · Cited by 10 · see citing works

Frequent Alzheimer’s disease neuropathological change in patients with glioblastoma

Greutter, L., Miller-Michlits, Y., Klotz, S., Reimann, R., Nenning, K., Platzek, S., Krause, E., Kiesel, B., Widhalm, G., Langs, G., et al. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae118 · Cited by 9 · see citing works

Cerebral amyloid angiopathy: a transient ischaemic attack mimic

Illsley, A., & Ramadan, H. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-3-255 · Cited by 8 · see citing works

Apolipoprotein E ε-4 as a genetic determinant of Alzheimer’s disease heterogeneity

Kotze, M. J., Brand, T., Pretorius, J., van Rensburg, S. J., & Luckhoff, H. K. (2015) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s41721 · Cited by 8 · see citing works

Neuropathological comorbidity, genetics and cognition in a Chinese community-based autopsy cohort

Wu, W., Wang, X., Xu, Y.-Y., Ma, C., Qian, X.-J., & Qiu, W.-Y. (2025) · Brain : a journal of neurology · doi:10.1093/brain/awaf039 · Cited by 5 · see citing works

Brain pericytes upregulate glutamate uptake by astrocytes in vitro through sodium-dependent transporter

Sakai, K., Takata, F., Iwao, T., Yasunaga, M., Yamanaka, G., Kataoka, Y., & Dohgu, S. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.017 · Cited by 5 · see citing works

APOE4, oxidative stress and decreased repair capacity - a no-brainer. Faulty lipid metabolism and increased levels of oxidative damage may be risk factors in the pathogenesis of late-onset dementia

Nayyar, A., & Chakalova, L. (2015) · Biodiscovery · doi:10.7750/biodiscovery.2015.17.1 · Cited by 4 · see citing works

Evaluation of B0-correction of relative CBF maps using tagging distance dependent Z-spectrum (TADDZ)

Damen, F. C., Tain, R., Thomas, R., Li, W., Tai, L. M., & Cai, K. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.10.002 · Cited by 2 · see citing works

Pathological findings from surgical specimens and long-term outcome in cerebral amyloid angiopathy patients with intracerebral hemorrhage

Liu, F., Liu, J., Wu, H., Wang, P., Liu, S., Wang, Z., Zhang, X., Jin, S., Ji, Y., Yan, X., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-26540-w · Cited by 1 · see citing works

Zerebrale Amyloidangiopathie

Drahn, S. (2025) · CardioVasc · doi:10.1007/s15027-025-3854-6 · Cited by 1 · see citing works

Neuropathology of Neurological Disorders

Rather, M. A., Khan, A., Javed, H., Jahan, S., Tabassum, R., & Begum, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-9404-5_1 · Cited by 1 · see citing works

Applied clinical neuroimaging in cerebral amyloid angiopathy and spontaneous intracerebral haemorrhage

Charidimou, A. (2015) · UCL Discovery (University College London) · Cited by 1 · see citing works

Relations Among Type 2 Diabetes, Arterial Stiffness and Cognitive Functioning

Dore, G. A. (2013) · DigitalCommons (California Polytechnic State University)

Genetics of Sporadic Cerebral Amyloid Angiopathy

Rannikmäe, K., & Sudlow, C. L. M. (2014) · InTech eBooks · doi:10.5772/58870

Senile plaques in Alzheimer’s disease arise from Aβ and Cathepsin D-enriched amyloidogenic mixtures out of intravascular hemolysis and Charcot-Bouchard aneurysm-related vascular degenerationPreprint

Fu, H., Li, J., Du, P., Jin, W., Gao, G., & Cui, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.17.100941

Amyloid (Congophilic) Angiopathy

(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-44592-4.50145-1

Capillary angiopathy and aquaporin-4 after Aβ immunisation in Alzheimer’s disease – potential relevance to Amyloid-Related Imaging AbnormalitiesPreprint

Harrison, C. H., Sakai, K., Johnston, D. A., Holmes, C., Boche, D., & Nicoll, J. A. R. (2022) · medRxiv · doi:10.1101/2022.12.08.22283144

Additional file 2 of DHCR24 reverses Alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xFAD mice

Zhang, W.-B., Huang, Y., Guo, X.-R., Zhang, M.-Q., 袁向山, & Zu, H.-B. (2024) · Figshare · doi:10.6084/m9.figshare.26598869

Additional file 3 of Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease

Lloyd, G. M., Trejo‐Lopez, J. A., Xia, Y., McFarland, K. N., Lincoln, S., Ertekin-Taner, N., Giasson, B. I., Yachnis, A. T., & Prokop, S. (2020) · Figshare · doi:10.6084/m9.figshare.11978586

Additional file 1 of DHCR24 reverses Alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xFAD mice

Zhang, W.-B., Huang, Y., Guo, X.-R., Zhang, M.-Q., 袁向山, & Zu, H.-B. (2024) · Figshare · doi:10.6084/m9.figshare.26598866

Additional file 1 of LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease

Koper, M. J., Tomé, S. O., Gawor, K., Belet, A., Schoor, E. V., Schaeverbeke, J. M., Vandenberghe, R. R., Vandenbulcke, M., Ghebremedhin, E., Otto, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20887331

Additional file 1 of Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease

Lloyd, G. M., Trejo‐Lopez, J. A., Xia, Y., McFarland, K. N., Lincoln, S., Ertekin-Taner, N., Giasson, B. I., Yachnis, A. T., & Prokop, S. (2020) · Figshare · doi:10.6084/m9.figshare.11978577

Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease

Thal, D., Papassotiropoulos, A., Saido, T., Griffin, W., Mrak, R. E., Kolsch, H., Tredici, K., Attems, J., & Ghebremedhin, E. (2010) · Newcastle University ePrints (Newcastle Univesity) · doi:10.25405/ncl.34118685

O2‐03‐03: Phenotypic and genetic subclassification of Alzheimer's disease

Thal, D. R., Koelsch, H., Papassotiropoulos, A., Saido, T. C., Griffin, S. T., Dooren, T. V., LEUVEN, F. V., & Ghebremedhin, E. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.336 · Cited by 20 · see citing works

Capillary CAA and perivascular Aβ-deposition: Two distinct features of Alzheimer's disease pathology

Attems, J., Yamaguchi, H., Saido, T. C., & Thal, D. R. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.030 · Cited by 63 · see citing works

Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease

Thal, D. R., Griffin, W. S. T., de Vos, R. A. I., & Ghebremedhin, E. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0366-2 · Cited by 372 · see citing works

Two Types of Sporadic Cerebral Amyloid Angiopathy

Thal, D. R., Ghebremedhin, E., Rüb, U., Yamaguchi, H., Del Tredici, K., & Braak, H. (2002) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1093/jnen/61.3.282 · Cited by 446 · see citing works